Építés alatt – nem éles oldal
Belépés
Résztvevőt keres itt: Egyesült ÁllamokFázis nélkül

Opioid Use Disorder and Pain

A legfontosabb adatok

Ki végzi
Yale University
Hol
New Haven (Egyesült Államok)A helyszín megnézése
Azonosító
Állapot
Toboroz
Résztvevők
180 fő, tervezett
Kezdés
2025. febr. 4.
Várható befejezés
2028. jan.
A vizsgálat típusa
Megfigyeléses, 2 csoport
A vizsgált kezelések
  • follow up interviews for 12 months to determine opioid use
A regiszteradat frissítve
2026. június 16.

Ki vehet részt

Életkor
21 év – 60 év
Nem
Nők és férfiak
Egészséges önkéntesek
Részt vehetnek

A regiszter feltételei, szó szerint

Mind a 67 feltétel megnézéseKevesebb

Ki nem vehet részt

  • Any subjects with foreign ferromagnetic metal objects in their body or other MR contraindications will be excluded. Individuals who previously worked in metal industry or with metal shavings (due to a risk of any remaining metal particles moving in the eye during the MRI)
  • Any significant current medical condition such as neurological, cardiovascular, endocrine, renal, hepatic, thyroid pathology
  • History of head injury with loss of consciousness (> 30 minutes)
  • Current or past DSM-IV or DSM 5 diagnosis of a major psychiatric disorder (other than opioid and nicotine use disorders) that required hospitalization, or that required daily medications for over 4 weeks. Such medications include antidepressants, anticholinergics, antipsychotics, anxiolytics, lithium, psychotropic drugs not otherwise specified including herbal products, drugs with psychomotor effects or with anxiolytics, stimulant, or antipsychotic properties, any other psychoactive drugs, and sedatives/hypnotics. Individuals with current depressive or anxiety symptoms requiring treatment or currently being treated for these symptoms will be excluded
  • Physically healthy with no major medical illnesses, history of head injury or any neurological illness
  • Any significant current medical condition such as neurological, cardiovascular, endocrine, renal, hepatic, thyroid pathology
  • History of head injury with loss of consciousness (> 30 minutes)
  • Current or past DSM-IV or DSM 5 diagnosis of a major psychiatric disorder (other than opioid and nicotine use disorders) that required hospitalization, or that required daily medications for over 4 weeks. Such medications include antidepressants, anticholinergics, antipsychotics, anxiolytics, lithium, psychotropic drugs not otherwise specified including herbal products, drugs with psychomotor effects or with anxiolytics, stimulant, or antipsychotic properties, any other psychoactive drugs, and sedatives/hypnotics. Individuals with current depressive or anxiety symptoms requiring treatment or currently being treated for these symptoms will be excluded
  • Physically healthy with no major medical illnesses, history of head injury or any neurological illness
  • Any significant current medical condition such as neurological, cardiovascular, endocrine, renal, hepatic, thyroid pathology
  • History of head injury with loss of consciousness (> 30 minutes)
  • Current or past DSM-IV or DSM 5 diagnosis of a major psychiatric disorder (other than opioid and nicotine use disorders) that required hospitalization, or that required daily medications for over 4 weeks. Such medications include antidepressants, anticholinergics, antipsychotics, anxiolytics, lithium, psychotropic drugs not otherwise specified including herbal products, drugs with psychomotor effects or with anxiolytics, stimulant, or antipsychotic properties, any other psychoactive drugs, and sedatives/hypnotics. Individuals with current depressive or anxiety symptoms requiring treatment or currently being treated for these symptoms will be excluded
  • Physically healthy with no major medical illnesses, history of head injury or any neurological illness
  • Any significant current medical condition such as neurological, cardiovascular, endocrine, renal, hepatic, thyroid pathology
  • History of head injury with loss of consciousness (> 30 minutes)
  • Current or past DSM-IV or DSM 5 diagnosis of a major psychiatric disorder (other than opioid and nicotine use disorders) that required hospitalization, or that required daily medications for over 4 weeks. Such medications include antidepressants, anticholinergics, antipsychotics, anxiolytics, lithium, psychotropic drugs not otherwise specified including herbal products, drugs with psychomotor effects or with anxiolytics, stimulant, or antipsychotic properties, any other psychoactive drugs, and sedatives/hypnotics. Individuals with current depressive or anxiety symptoms requiring treatment or currently being treated for these symptoms will be excluded
  • Meet criteria for current or history of any Axis I (except nicotine use) disorder
  • Any significant current medical condition such as neurological, cardiovascular, endocrine, renal, hepatic, thyroid pathology. History of head injury with loss of consciousness (> 30 minutes)
  • Between ages 21-60 years old
  • Between ages 21-60 years old
  • Between ages 21-60 years old
  • Between ages 1821-60 years old
  • Pregnant or lactating women will not be recruited for the study
  • Cannot or are not willing to lie comfortably flat on his/her back for up to 2 hours in the MRI scanner (self-report)
  • Body weight > 550 lbs. The MR scanner bed is tested to a weight limit of 550 lbs
  • No pPlans to relocate out of state in the next 12 months (for follow-up purposes)
  • Still experiencing significant withdrawal symptoms; Individuals with regular opioid use; To be eligible for inclusion in the study, an individual must meet all of the following criteria:
  • Able to read and write and provide written informed consent
  • Use non-prescribed opioids on a weekly basis or more
  • No plans to relocate out of state in the next 12 months (for follow-up purposes)
  • Speak English
  • Any subjects with foreign ferromagnetic metal objects in their body or other MR contraindications will be excluded
  • Pregnant or lactating women will not be recruited for the study
  • Cannot or are not willing to lie comfortably flat on his/her back for up to 2 hours in the MRI scanner (self-report)
  • Body weight > 550 lbs. The MR scanner bed is tested to a weight limit of 550 lbs; Individuals with regular opioid use; To be eligible for inclusion in the study, an individual must meet all of the following criteria:
  • Able to read and write and provide written informed consent
  • Use non-prescribed opioids on a weekly basis or more
  • No plans to relocate out of state in the next 12 months (for follow-up purposes)
  • Speak English
  • Any subjects with foreign ferromagnetic metal objects in their body or other MR contraindications will be excluded
  • Pregnant or lactating women will not be recruited for the study
  • Cannot or are not willing to lie comfortably flat on his/her back for up to 2 hours in the MRI scanner (self-report)
  • Body weight > 550 lbs. The MR scanner bed is tested to a weight limit of 550 lbs; Individuals with regular opioid use; To be eligible for inclusion in the study, an individual must meet all of the following criteria:
  • Able to read and write and provide written informed consent
  • Use non-prescribed opioids on a weekly basis or more
  • No plans to relocate out of state in the next 12 months (for follow-up purposes)
  • Speak English
  • Any subjects with foreign ferromagnetic metal objects in their body or other MR contraindications will be excluded
  • Pregnant or lactating women will not be recruited for the study
  • Cannot or are not willing to lie comfortably flat on his/her back for up to 2 hours in the MRI scanner (self-report)
  • Body weight > 550 lbs. The MR scanner bed is tested to a weight limit of 550 lbs; Healthy controls (HC) Inclusion Criteria
  • Able to read and write and provide written informed consent
  • Demographics matching OUD participants
  • Speak English
  • Any subjects with foreign ferromagnetic metal objects in their body or other MR contraindications will be excluded
  • Pregnant or lactating women will not be recruited for the study. 6. Cannot or are not willing to lie comfortably flat on his/her back for up to 2 hours in the MRI scanner (self-report)
  • Body weight > 550 lbs. The MR scanner bed is tested to a weight limit of 550 lbs

Egyéb feltételek

  • Patients with Opioid Use Disorder (OUD)
  • To be eligible for inclusion in the study, an individual must meet all of the following criteria:
  • Between ages 21-60 years old
  • Able to read and write and provide written informed consent
  • Meet DSM-5 criteria for moderate to severe opioid use disorder; self-reported excessive opioid use prior to study entry and verified by urine toxicology testing; seeking treatment for their OUD
  • Physically healthy with no major medical illnesses, history of head injury or any neurological illness
  • No plans to relocate out of state in the next 12 months (for follow-up purposes)
  • Currently seeking treatment or currently receiving treatment for OUD
  • Speak English
  • Have been enrolled in an inpatient or outpatient treatment program for OUD for at least 4 weeks

A fő feltételek kérdésként

Magadról válaszolj. Ez nem döntés: hogy részt vehetsz-e, azt csak a vizsgálat csapata mondhatja meg.

  • 21 és 60 év között vagy?

Ez a vizsgálat jelenleg itt érhető el: Egyesült Államok.

  • Connecticut Mental Health Center, S105New Haven, Egyesült ÁllamokContact: Thang M Le, PhDRésztvevőt keres

A vizsgálatról

Mit akar kideríteni a vizsgálat

The goal of this observational study is to characterize the brain processes of pain avoidance learning dysfunctions in individuals with opioid use disorder (OUD). The main questions it aims to answer are:

A teljes eredeti leírásKevesebb

Compared with healthy controls, do those with OUD exhibit impaired avoidance learning in response to pain? What are the brain processes that are associated with this avoidance learning dysfunction? Do these brain processes serve to predict future use or relapse?

Researchers will compare those with OUD and healthy controls to determine avoidance learning dysfunction and its relationship with opioid use.

Participants will be performing a learning task inside an fMRI scanner. Those with OUD will also be followed up for a year to determine future opioid use.

A vizsgálat 2 csoportja

  • opioid use disorder

    individuals with OUD diagnosis

    Kezelés: follow up interviews for 12 months to determine opioid use

  • Healthy controls

    Healthy individuals without substance use disorders

Kérdések a vizsgálat csapatának

  1. Milyen gyakran kell bejárnom, és egy-egy alkalom mennyi ideig tart?
  2. Megtérítik az utazási költséget?
  3. Megtarthatom a saját orvosomat?
  4. Mi történik, ha ki akarok lépni?

Contact the study team: see the registry record → Contacts and Locations

Oldal nyomtatása az orvosomnak

Adatok és források

Regiszteradat
Szerepel a ClinicalTrials.gov-on.
Kérdések a feltételekről
Forrás: NCT06800703: ki vehet részt
A regiszteradat frissítve
2026. június 16.